Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AGILNASDAQ:ALBTNASDAQ:ASPANASDAQ:RVYL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGILAgileThought$0.14$0.06▼$4.68$10.32M0.072.78 million shs216.69 million shsALBTAvalon GloboCare$3.00-4.8%$3.62$2.11▼$12.60$5.68M0.03475,629 shs14,461 shsASPAAbri SPAC I$21.91$8.70▼$38.40$1.69M-0.4236,881 shs464 shsRVYLRyvyl$0.70+3.7%$0.80$0.36▼$2.40$5.86M4.012.84 million shs736,334 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGILAgileThought0.00%0.00%0.00%0.00%0.00%ALBTAvalon GloboCare-4.76%-7.98%-19.35%-37.63%-55.60%ASPAAbri SPAC I0.00%0.00%0.00%0.00%-97.40%RVYLRyvyl+3.72%+4.48%+1.46%-28.53%-55.95%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGILAgileThoughtN/AN/AN/AN/AN/AN/AN/AN/AALBTAvalon GloboCare2.2476 of 5 stars0.05.00.04.33.01.70.0ASPAAbri SPAC IN/AN/AN/AN/AN/AN/AN/AN/ARVYLRyvyl1.3975 of 5 stars0.02.00.00.03.02.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGILAgileThought 0.00N/AN/AN/AALBTAvalon GloboCare 0.00N/AN/AN/AASPAAbri SPAC I 0.00N/AN/AN/ARVYLRyvyl 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownLatest AGIL, RVYL, ASPA, and ALBT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/3/2025RVYLRyvylHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGILAgileThought$176.85M0.00N/A0.95$1.66 per share0.00ALBTAvalon GloboCare$1.37M4.15N/AN/A($17.22) per share-0.17ASPAAbri SPAC IN/AN/AN/AN/A($3.38) per shareN/ARVYLRyvyl$54.36M0.11N/AN/A$4.36 per share0.16Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGILAgileThought-$20.18M-$1.45N/AN/AN/A-41.19%-26.08%-7.29%N/AALBTAvalon GloboCare-$16.71M-$19.96N/A∞N/A-1,125.59%N/A-73.69%8/18/2025 (Estimated)ASPAAbri SPAC I-$2.50MN/A0.00N/AN/AN/AN/A-6.55%N/ARVYLRyvyl-$53.10M-$8.52N/AN/AN/A-78.67%-114.73%-13.60%8/12/2025 (Estimated)Latest AGIL, RVYL, ASPA, and ALBT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025RVYLRyvyl-$0.27-$0.29-$0.02-$0.33$15.54 million$14.13 million5/13/2025Q1 2025ALBTAvalon GloboCareN/A-$1.43N/A-$1.43N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGILAgileThoughtN/AN/AN/AN/AN/AALBTAvalon GloboCareN/AN/AN/AN/AN/AASPAAbri SPAC IN/AN/AN/AN/AN/ARVYLRyvylN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGILAgileThought0.010.310.31ALBTAvalon GloboCareN/A0.110.11ASPAAbri SPAC IN/A0.090.09RVYLRyvyl2.800.960.96Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGILAgileThought28.18%ALBTAvalon GloboCare1.42%ASPAAbri SPAC I51.39%RVYLRyvyl17.37%Insider OwnershipCompanyInsider OwnershipAGILAgileThought40.30%ALBTAvalon GloboCare37.30%ASPAAbri SPAC I58.00%RVYLRyvyl30.76%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGILAgileThought2,50452.40 million31.29 millionNot OptionableALBTAvalon GloboCare51.89 million686,000Not OptionableASPAAbri SPAC I2,0212.41 million1.01 millionNot OptionableRVYLRyvyl508.36 million5.78 millionNo DataAGIL, RVYL, ASPA, and ALBT HeadlinesRecent News About These CompaniesRYVYL Executes Strategic Actions Enhancing Its Business Plan and Files S-1 Registration StatementJune 16 at 7:06 AM | globenewswire.comRYVYL Appoints Industry Veteran Brett Moyer to Its Board of DirectorsJune 16 at 7:05 AM | globenewswire.comRYVYL converts senior note to equity, strengthens balance sheetJune 8, 2025 | uk.investing.comRyvyl completes debt-to-equity conversionJune 6, 2025 | msn.comRYVYL Announces Conversion for Remainder of 8% Senior Convertible Note; Successfully Completes Process of Delevering Balance SheetJune 6, 2025 | globenewswire.comRVYL stock touches 52-week low at $0.52 amid market challengesJune 1, 2025 | investing.comRYVYL Receives Extension to Comply with Nasdaq Listing Rule 5550(b)May 27, 2025 | finance.yahoo.comRyvyl: Q1 Earnings SnapshotMay 20, 2025 | timesunion.comRYVYL Inc.: RYVYL Ceases Negotiations to Restructure Pre-funded Asset SaleMay 15, 2025 | finanznachrichten.deRYVYL Ceases Negotiations to Restructure Pre-funded Asset SaleMay 14, 2025 | globenewswire.comRYVYL Inc. negotiates asset sale terms, enters standstillApril 26, 2025 | investing.comRYVYL Enters Standstill Agreement on Sale of EU SubsidiaryApril 25, 2025 | marketwatch.comRyvyl enters negotiations to restructure pre-funded asset saleApril 25, 2025 | markets.businessinsider.comRYVYL Enters Negotiations to Restructure Pre-funded Asset Sale to Debt and/or EquityApril 24, 2025 | manilatimes.netRyvyl Grants RSAs to Executives and EmployeesApril 11, 2025 | tipranks.comRyvyl EU Payments-as-a-Service Contracts onboarding new accountsApril 3, 2025 | markets.businessinsider.comRYVYL EU Payments-as-a-Service Contracts Rapidly Onboarding New AccountsApril 2, 2025 | markets.businessinsider.comRYVYL Inc.: RYVYL Reports Q4 2024 and Full Year 2024 Financial Results and Provides a Business UpdateMarch 31, 2025 | finanznachrichten.deRYVYL Reports Q4 2024 and Full Year 2024 Financial Results and Provides a Business UpdateMarch 31, 2025 | markets.businessinsider.comRyvyl reports Q4 EPS (91c) vs ($5.43) last yearMarch 31, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAGIL, RVYL, ASPA, and ALBT Company DescriptionsAgileThought NASDAQ:AGILAgileThought, Inc. provides digital transformation services in the United States and Latin America. It offers organizational transformations, training and certifications, and product management services. The company provides application engineering and DEVOPS, cloud architecture and migration, data analytics, automation, application modernization, UX/UI design, artificial intelligence, and machine learning services. In addition, it offers lifecycle management support and multi cloud services. The company serves professional services, healthcare, pharmacy, financial services, energy, and utilities industries. AgileThought, Inc. was founded in 2000 and is headquartered in Irving, Texas. On August 28, 2023, AgileThought, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with A.N. Global Group Holdings LTD.Avalon GloboCare NASDAQ:ALBT$3.00 -0.15 (-4.76%) Closing price 06/16/2025 03:59 PM EasternExtended Trading$3.06 +0.06 (+2.00%) As of 06/16/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing mRNA-based Flash-CAR cell therapy platform. In addition, the company develops Avalon clinical-grade tissue-specific exosome (ACTEX); AVA-Trap, a therapeutic program provides an effective therapeutic option to combat COVID-19 and other life-threatening conditions involving cytokine storms; offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Avalon GloboCare Corp. has strategic partnership with HydroPeptide, LLC to engage in co-development and commercialization of a series of clinical-grade, exosome-based cosmeceutical, and orthopedic products; and corporate research agreement with the University of Pittsburgh of the Commonwealth System of Higher Education. The company was founded in 2016 and is headquartered in Freehold, New Jersey.Abri SPAC I NASDAQ:ASPAAbri SPAC I, Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination involving one or more businesses or assets. The company was incorporated in 2021 and is based in Beverly Hills, California.Ryvyl NASDAQ:RVYL$0.70 +0.03 (+3.72%) Closing price 06/16/2025 04:00 PM EasternExtended Trading$0.68 -0.03 (-3.59%) As of 04:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ryvyl Inc., a technology company, engages in the development, marketing, and sale of blockchain-based payment solutions in North America, Europe, and Asia. The company's blockchain-based systems facilitate, record, and store a volume of tokenized assets representing cash or data on a blockchain-based ledger. Its products include QuickCard Payment System, a physical and virtual payment card processing management system, including software that facilitates on and off ramp e-wallet management; Coyni, a digital token platform, which offers custodial assurance by utilizing its stable coin and blockchain technology in a closed-loop ecosystem; and ChargeSavvy, an end-to-end POS solution comprising software and hardware for the restaurant and hospitality industry. It serves customers in various industries, including foreign exchange, retail, and e-commerce sectors. The company was formerly known as GreenBox POS and changed its name to Ryvyl Inc. in October 2022. Ryvyl Inc. is based in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
